Home » Ra Medical Systems Achieves FDA Clearance For Peripheral Artery Disease Treatment
Ra Medical Systems Achieves FDA Clearance For Peripheral Artery Disease Treatment
May 30, 2017
The FDA has granted marketing clearance to Ra Medical Systems for its DABRA System for peripheral artery disease treatment.
The device is a catheter and excimer laser system for the treatment of complex and diffuse arterial blockages in the lower vessels.
The single-use catheter produces a lumen while minimizing trauma to the vasculature. It is a full catheter tip forward cutter, without the “dead-space” of fiber optic bundle catheters.
The DABRA laser photochemically ablates arterial blockages, reducing calcium, thrombus and atheroma, minimizing downstream debris. The portable laser weighs about 100 pounds. — Cynthia Jessup
Upcoming Events
-
21Oct